131 related articles for article (PubMed ID: 23391717)
1. Prognostic model to identify patients with myelofibrosis at the highest risk of transformation to acute myeloid leukemia.
Quintás-Cardama A; Kantarjian H; Pierce S; Cortes J; Verstovsek S
Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):315-318.e2. PubMed ID: 23391717
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow fibrosis at diagnosis predicts survival for primary acute myeloid leukemia.
Wu Z; Chen R; Wu L; Zou L; Ding F; Wang M; Liu X
Clin Transl Oncol; 2017 Dec; 19(12):1462-1468. PubMed ID: 28589431
[TBL] [Abstract][Full Text] [Related]
3. Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis.
Masarova L; Bose P; Daver N; Pemmaraju N; Newberry KJ; Manshouri T; Cortes J; Kantarjian HM; Verstovsek S
Leuk Res; 2017 Aug; 59():110-116. PubMed ID: 28601551
[TBL] [Abstract][Full Text] [Related]
4. Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model.
Vallapureddy RR; Mudireddy M; Penna D; Lasho TL; Finke CM; Hanson CA; Ketterling RP; Begna KH; Gangat N; Pardanani A; Tefferi A
Blood Cancer J; 2019 Jan; 9(2):12. PubMed ID: 30683837
[TBL] [Abstract][Full Text] [Related]
5. Decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia.
Lin Y; Lin R; Zhou G; Liu Y; Dong W; Cao Y; Xie X; Gu W
J Int Med Res; 2019 Feb; 47(2):1064-1071. PubMed ID: 30616420
[TBL] [Abstract][Full Text] [Related]
6. Analysis of clinical characteristics of bone marrow proliferative tumor progression to acute myeloid leukemia.
Li Y; Zhang XY; Han J; Wang L
Cancer Biomark; 2018; 23(4):469-472. PubMed ID: 30452397
[TBL] [Abstract][Full Text] [Related]
7. The risk of early mortality in elderly patients with newly diagnosed acute myeloid leukemia.
Liu CJ; Hong YC; Kuan AS; Yeh CM; Tsai CK; Liu YC; Hsiao LT; Wang HY; Ko PS; Chen PM; Liu JH; Gau JP
Cancer Med; 2020 Feb; 9(4):1572-1580. PubMed ID: 31902138
[TBL] [Abstract][Full Text] [Related]
8. Leukemic transformation in patients with myeloproliferative neoplasms: a population-based retrospective study.
Shrestha R; Giri S; Armitage JO; Bhatt VR
Future Oncol; 2017 Jun; 13(14):1239-1246. PubMed ID: 28589759
[TBL] [Abstract][Full Text] [Related]
9. Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center.
Ciurea SO; Labopin M; Socie G; Volin L; Passweg J; Chevallier P; Beelen D; Milpied N; Blaise D; Cornelissen JJ; Fegueux N; Polge E; Kongtim P; Rondon G; Esteve J; Mohty M; Savani BN; Champlin RE; Nagler A
Cancer; 2018 May; 124(10):2134-2141. PubMed ID: 29469961
[TBL] [Abstract][Full Text] [Related]
10. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of clinical features, gene mutation, and prognostic characteristics in de novo acute myeloid leukemia patients with myelofibrosis].
Dong XY; Li YL; Wu CY; Liu YM; Zhang L; Cheng W; Shang BJ; Zhang L; Zhu ZM
Zhonghua Xue Ye Xue Za Zhi; 2020 Sep; 41(9):731-736. PubMed ID: 33113604
[No Abstract] [Full Text] [Related]
12. [Prognostic factor analysis of 77 old patients with acute myelogenous leukemia].
Shao B; Gao YR; Wang C; Yan SK; Cai Q; Jiang JL; Yang J; Bai HT; Zhao M; Zhao CX
Ai Zheng; 2006 Aug; 25(8):1007-12. PubMed ID: 16965684
[TBL] [Abstract][Full Text] [Related]
13. Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemia.
Suleiman Y; Dalia S; Liu JJ; Bowers JW; Padron E; Lancet JE; Fulp W; Moscinski LC; Komrokji RS; Zuckerman KS; Zhang L
Leuk Res; 2016 Mar; 42():52-8. PubMed ID: 26894965
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide treatment in a myelofibrosis patient with leukemia transformation.
Huang WH; Li MS; Chu SC; Wang TF; Kao RH; Wu YF
Int J Hematol; 2014 Feb; 99(2):188-92. PubMed ID: 24307514
[TBL] [Abstract][Full Text] [Related]
15. The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.
Wang R; Gao X; Yu L
BMC Cancer; 2019 Apr; 19(1):389. PubMed ID: 31023266
[TBL] [Abstract][Full Text] [Related]
16. Contribution of comorbidities and grade of bone marrow fibrosis to the prognosis of survival in patients with primary myelofibrosis.
Lekovic D; Gotic M; Perunicic-Jovanovic M; Vidovic A; Bogdanovic A; Jankovic G; Cokic V; Milic N
Med Oncol; 2014 Mar; 31(3):869. PubMed ID: 24500865
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis.
Neukirchen J; Lauseker M; Hildebrandt B; Nolting AC; Kaivers J; Kobbe G; Gattermann N; Haas R; Germing U
Cancer; 2017 Dec; 123(23):4608-4616. PubMed ID: 28746789
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
19. Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia.
Kamath GR; Tremblay D; Coltoff A; Caro J; Lancman G; Bhalla S; Najfeld V; Mascarenhas J; Taioli E
Carcinogenesis; 2019 Jul; 40(5):651-660. PubMed ID: 30715157
[TBL] [Abstract][Full Text] [Related]
20. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.
Prats-Martín C; Burillo-Sanz S; Morales-Camacho RM; Pérez-López O; Suito M; Vargas MT; Caballero-Velázquez T; Carrillo-Cruz E; González J; Bernal R; Pérez-Simón JA
Cancer Med; 2020 Jun; 9(11):3637-3646. PubMed ID: 32216059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
